Objective: The use of VATS metastasectomy remains controversial because of doubt surrounding its ability to remove palpable but CT occult lesions. We aim to evaluate our policy of elective VATS and compare it with our results with open metastasectomy.

Methods: Pulmonary metastasectomy was performed for metastatic colorectal adenocarcinoma in 52 patients: 27 open and 25 VATS over 8 years. The age and sex distribution was similar: median age was 66 for open and 69 years for VATS, p=0.48, 70% male in open and 64% male in VATS, p=0.31. Liver metastases were present in 37% in the open and 32% in the VATS group, p=0.46. The choice of surgical approach was dependent on the distance of the lesion from the surface of the lung. We examined the survival using the Kaplan-Meier method and we tested for differences in the incidence of missed lesions, pulmonary disease progression and repeat metastasectomy.

Results: There was no in-hospital mortality. There was no difference in the incidence of missed lesions (1 in VATS, none in open, p=0.48), pulmonary disease progression (11 in open, 9 in VATS, p=0.47) or recurrence in the same lobe (4 in open, 3 in VATS, p=0.54). Median follow-up was 22 (1-70) months and there was no difference to the estimated actuarial survival. Mean survival for the open group was 47 months, SE 6 with 95% CI 36-59 months and mean survival for the VATS group 35.4 months, SE 3 with 95% CI 30-41.3 months. The estimated 1- and 2-year survival was 90% and 80% for open and 90% and 72% for VATS.

Conclusions: The selective use of VATS therapeutic metastasectomy in conjunction with multi-detector CT is justified in metastatic colorectal adenocarcinoma. The insertion of the surgical digit is not mandatory. Trust the radiologist's eye.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejcts.2009.03.050DOI Listing

Publication Analysis

Top Keywords

open vats
12
open
11
vats
11
pulmonary metastasectomy
8
metastatic colorectal
8
colorectal adenocarcinoma
8
vats group
8
incidence missed
8
missed lesions
8
pulmonary disease
8

Similar Publications

Inpatient lung cancer surgery outcomes in Illinois.

Surg Pract Sci

September 2023

Division of General Internal Medicine, Northwestern University Feinberg School of Medicine, 750 N. Lakeshore Dr. 10th Floor, Chicago, IL 60611, United States.

Objective: This study analyzed inpatient mortality and length of stay for lung cancer surgery in Illinois hospitals by patient clinical and demographic characteristics, procedure types, and hospital and surgeon volume.

Methods: The study analyzed lung cancer patients who underwent lobectomy or sublobar resection at Illinois hospitals from 2016 to June 2022. Trends in procedure type, inpatient mortality, one-day length of stay (LOS), and prolonged LOS (>10 days) were evaluated.

View Article and Find Full Text PDF

Background Lung resection is a complex surgical procedure performed in children to address various pulmonary conditions. The success of this surgical intervention in these patients lies in a multidisciplinary approach, with anesthetic management playing a critical role in ensuring the safety and efficacy of the procedure. Methods After approval by the local ethics committee, clinical data of 17 pediatric patients who underwent lung resection in our hospital from January 2012 to December 2022 were retrospectively analyzed.

View Article and Find Full Text PDF

Mediastinal lymphangiomas are rare benign tumors arising from lymphatic system malformations, most commonly seen in pediatric populations. In adults, they are exceedingly rare and present diagnostic challenges due to nonspecific symptoms and imaging overlap with other mediastinal masses. Diagnosis is typically based on imaging, including CT and MRI, with histopathology confirming the diagnosis.

View Article and Find Full Text PDF

Background: Lung cancer is the first cause of cancer-related death. Awake lung resection is a new frontier of the concept of minimally invasive surgery. Our purpose is to demonstrate the feasibility of this technique for lobar and sublobar lung resection in NSCLC patients.

View Article and Find Full Text PDF

: Significant intraoperative and postoperative blood loss are rare but possibly life-threatening complications after lung resection surgery either during open or minimally invasive procedures. Microporous Polysaccharide Haemospheres (ARISTA™AH) have demonstrated time-efficient haemostasis, lower postoperative blood volumes and a lower blood transfusion requirement, without any identified adverse events across other specialities. The primary aim of our study was to evaluate the impact of ARISTA™AH on short-term postoperative outcomes in thoracic surgery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!